维普中文期刊产品整合服务
10篇 您的检索式:作者名="Retlich"
    题名 作者 年代 出处 被引量
1Pharmacokinetics of linagliptin in subjects with hepatic impairment显示文摘Ulrike Graefe‐Mody Peter Rose Silke Retlich Arne Ring Lisa Waldhauser Rodica Cinca Hans‐Juergen Woerle 2012British Journal of Clinical Pharmacology2012,,1:2
2Pharmacokinetics of linagliptin in subjects with hepatic impairment显示文摘Ulrike Graefe‐Mody Peter Rose Silke Retlich Arne Ring Lisa Waldhauser Rodica Cinca Hans‐Juergen Woerle 2012British Journal of Clinical Pharmacology2012,,1:1
3Clinical pharmacokinetics and pharmacodynamics of linagliptin显示文摘GRAEFE-MODY U RETLICH S FRIEDRICH C 2012Clin Pharmacokinet2012,51,7:1
4Clinical pharmacokinetics and pharmacodynamics of linagliptin 显示文摘GRAEFE- MODY U RETLICH S FRIEDRICH C 2012Clin Pharmacokinet2012,51,7:1
5Impact of target-mediated drug disposition on linagliptin pharmacokinetics and DPP- 4 inhibition in type 2 diabetic patients显示文摘RETLICH S DUVAL V GRAEFE-MODY U 2010J Clin Pharmacol2010,50,8:1
6Binding to dipeptidyl peptidase- 4 determines the disposition of linagliptin (BI 1356)-investigations in DPP-4 deficient and wildtype rats 显示文摘RETLICH S WITHOPF B GREISCHEL A 2009Biopharm Drug Dispos2009,30,8:1
7Pharmaco- kinetics of linagliptin in subjects with hepatic impairment显示文摘GRAEFE-MODY U ROSE P RETLICH S 2012Br J Clin Pharmacol2012,13,10:1
8Pharmacokinetics of linagliptin in subjects with hepatic impairment显示文摘Graefe-Mody U Rose P Retlich S 2012Br J Clin Pharmacol2012,74,1:1
9Pharmacokinetics of linagliptin in subjects with hepatic impairment显示文摘Graefe Mody U Rose P Retlich S 0,,1:1
10Pharmacokinetics of linagliptin in subjects with hepatic impairment 显示文摘Grafe Mody U Rose P Retlich S 2012Br J Clin Pharmacol2012,74,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费